
TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 17
IS  - S2
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.13053
DO  - doi:10.1111/codi.13053
SP  - 38
EP  - 101
PY  - 2015
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Vox Sanguinis
VL  - 101
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2011.01498_1.x
DO  - doi:10.1111/j.1423-0410.2011.01498_1.x
SP  - 1
EP  - 79
PY  - 2011
ER  - 

TY  - JOUR
TI  - American Society of Transplant Surgeons: 18th Annual State of the Art Winter Symposium
JO  - American Journal of Transplantation
VL  - 18
IS  - S2
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14572
DO  - doi:10.1111/ajt.14572
SP  - 13
EP  - 99
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 109
IS  - S1
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12304
DO  - doi:10.1111/vox.12304
SP  - 1
EP  - 379
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 111
IS  - S1
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12429
DO  - doi:10.1111/vox.12429
SP  - 7
EP  - 305
PY  - 2016
ER  - 

TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650221408
DO  - doi:10.1002/jbmr.5650221408
SP  - s302
EP  - s351
PY  - 2007
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Developmental Medicine & Child Neurology
JA  - Dev Med Child Neurol
VL  - 61
IS  - S2
SN  - 0012-1622
UR  - https://doi.org/10.1111/dmcn.14244
DO  - doi:10.1111/dmcn.14244
SP  - 4
EP  - 61
PY  - 2019
ER  - 

TY  - JOUR
TI  - SCIENTIFIC ABSTRACTS
JO  - Journal of General Internal Medicine
VL  - 19
IS  - s1
SN  - 0884-8734
UR  - https://doi.org/10.1111/j.1525-1497.2004.S1006_5.x
DO  - doi:10.1111/j.1525-1497.2004.S1006_5.x
SP  - 109
EP  - 241
PY  - 2004
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - BJU International
VL  - 108
IS  - s1
SN  - 1464-4096
UR  - https://doi.org/10.1111/j.1464-410X.2011.10264.x
DO  - doi:10.1111/j.1464-410X.2011.10264.x
SP  - 16
EP  - 60
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session 5
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr011
DO  - doi:10.1093/eurjhf/hsr011
SP  - S218
EP  - S263
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Ophthalmologica
JA  - Acta Ophthalmol
VL  - 96
IS  - S260
SN  - 1755-375X
UR  - https://doi.org/10.1111/aos.13736
DO  - doi:10.1111/aos.13736
SP  - 3
EP  - 49
PY  - 2018
ER  - 

TY  - JOUR
TI  - Saturday 23 April 2016
JO  - Journal of Medical Radiation Sciences
JA  - J Med Radiat Sci
VL  - 63
IS  - S1
SN  - 2051-3895
UR  - https://doi.org/10.1002/jmrs.1_166
DO  - doi:10.1002/jmrs.1_166
SP  - 45
EP  - 85
PY  - 2016
ER  - 

TY  - JOUR
TI  - Oral abstracts
JO  - Journal of Diabetes Investigation
JA  - J Diabetes Investig
VL  - 9
IS  - S1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.12938
DO  - doi:10.1111/jdi.12938
SP  - 19
EP  - 46
PY  - 2018
ER  - 

TY  - JOUR
TI  - ACVIM Forum Abstracts
JO  - Journal of Veterinary Internal Medicine
VL  - 21
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2007.tb03006.x
DO  - doi:10.1111/j.1939-1676.2007.tb03006.x
SP  - 559
EP  - 670
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts of The Movement Disorder Society's Thirteenth International Congress of Parkinson's Disease and Movement Disorders
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 24
IS  - S1
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.22628
DO  - doi:10.1002/mds.22628
SP  - S1
EP  - S653
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Journal of Paediatrics and Child Health
VL  - 47
IS  - s1
SN  - 1034-4810
UR  - https://doi.org/10.1111/j.1440-1754.2011.02046.x
DO  - doi:10.1111/j.1440-1754.2011.02046.x
SP  - 8
EP  - 59
PY  - 2011
ER  - 

TY  - JOUR
AU  - Phillips, A
AU  - Sundar, S
AU  - Singh, K
AU  - Pounds, R
AU  - Nevin, J
AU  - Kehoe, S
AU  - Balega, J
AU  - Elattar, A
TI  - The NICE classification for ‘Ultra-radical (extensive) surgery for advanced ovarian cancer’ guidance does not meaningfully predict postoperative complications: a cohort study
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 126
IS  - 1
SN  - 1470-0328
UR  - https://doi.org/10.1111/1471-0528.15423
DO  - doi:10.1111/1471-0528.15423
SP  - 96
EP  - 104
KW  - Morbidity
KW  - NICE
KW  - ovarian cancer
KW  - surgery
KW  - ultra-radical
PY  - 2019
AB  - Objective To determine which descriptors of cytoreductive surgical extent in advanced ovarian cancer (AOC) best predict postoperative morbidity. Design Retrospective notes review. Setting A gynaecological cancer centre in the UK. Population Six hundred and eight women operated on for AOC over a period of 114 months at a tertiary cancer centre, between 16 August 2007 and 16 February 2017. Methods Outcome data were analysed by six approaches to classify the extent of surgery: standard/ultra-radical surgery; standard/radical/supra-radical surgery; presence/absence of gastrointestinal resections; low/intermediate/high surgical complexity score (SCS); presence of bowel anastomoses and/or diaphragmatic surgery; and the presence/absence of multiple bowel resections. Main outcome measures Major (grades 3?5) postoperative morbidity and mortality. Results Forty-three (7.1%) patients experienced major complications. Grade-5 complications occurred in six patients (1.0%). Patients who underwent multiple bowel resections had a relative risk (RR) of 7.73 (95% confidence interval, 95% CI 3.92?15.26), patients with a high SCS had an RR of 6.12 (95% CI 3.25?11.52), patients with diaphragmatic surgery and gastrointestinal anastomosis had an RR of 5.57 (95% CI 2.65?11.72), patients with ?any gastrointestinal resection? had an RR of 4.69 (95% CI 2.66?8.24), patients with ultra-radical surgery had an RR of 4.65 (95% CI 2.26?8.79), and patients with supra-radical surgery had an RR of 4.20 (95% CI 2.35?7.51) of grades 3?5 morbidity, compared with patients undergoing standard surgery as defined by the National Institute for Health and Care Excellence (NICE) in the UK. No significant difference was seen in the rate of major morbidity between standard (6/59, 10.2%) and ultra-radical (9/81, 11.1%) surgery within the cohort who had intermediate complex surgery (P > 0.05). Conclusions The numbers of procedures performed significantly correlate with major morbidity. The number of procedures performed better predicted major postoperative morbidity than the performance of certain ?high risk? procedures. We recommend using SCS to define a higher risk operation. NICE should re-evaluate the use of the term ?ultra-radical? surgery. Tweetable abstract Multiple bowel resection is the best predictor of morbidity and is more predictive than ?ultra-radical surgery?.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12646
DO  - doi:10.1111/tri.12646
SP  - 22
EP  - 59
PY  - 2015
ER  - 

TY  - JOUR
AU  - Li, Yiting
AU  - Dang, Tu Anh
AU  - Shen, Jianhe
AU  - Perlaky, Laszlo
AU  - Hicks, John
AU  - Murray, Jeffrey
AU  - Meyer, William
AU  - Chintagumpala, Murali
AU  - Lau, Ching C.
AU  - Man, Tsz-Kwong
TI  - Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma
JO  - PROTEOMICS
JA  - Proteomics
VL  - 6
IS  - 11
SN  - 1615-9853
UR  - https://doi.org/10.1002/pmic.200500472
DO  - doi:10.1002/pmic.200500472
SP  - 3426
EP  - 3435
KW  - Molecular classification
KW  - Osteosarcoma
KW  - SELDI
KW  - Serum amyloid protein A
PY  - 2006
AB  - Abstract Osteosarcoma (OS) is the most common malignant bone tumor in children. To identify a plasma proteomic signature that can detect OS, we used SELDI MS to perform proteomic profiling on plasma specimens from 29?OS and 20?age-matched osteochondroma?(OC) patients. Nineteen statistically significant ion peaks that were differentially expressed in OS when compared with OC patients were identified (p < 0.001 and false discovery rate < 10%). Using the proteomic profiles, we constructed a multivariate 3-nearest neighbors classifier to distinguish OS from OC patients with a sensitivity of 97% and a specificity of 80% based on external leave-one-out crossvalidation. Permutation test showed that the classification result was statistically significant (p < 0.00005). One of the proteins (m/z?11?704) in the proteomic signature was identified as serum amyloid protein?A (SAA) by PMF. The higher plasma level of SAA in OS patients was further validated by Western blotting when compared to that of osteochrondroma patients and normal subjects as reference. The classifier based on this plasma proteomic signature may be useful to differentiate malignant bone cancer from benign bone tumors and for early detection of OS in high-risk individuals.
ER  - 

TY  - JOUR
TI  - Poster Presentation
JO  - Haemophilia
JA  - Haemophilia
VL  - 19
IS  - s2
SN  - 1351-8216
UR  - https://doi.org/10.1111/hae.12083
DO  - doi:10.1111/hae.12083
SP  - 10
EP  - 82
PY  - 2013
ER  - 
